News & Insights

Message from Dana Deardorff

March 2023 Newsletter
Fostering equitable health systems to achieve UHC.jpg Fostering equitable health systems to achieve UHC.jpg
A group of doctors posing for a picture at a Penda Medical Center in Nairobi, Kenya.

The goal of achieving Universal Health Coverage (UHC) has never been a more prominent global health priority.

Our strategy at Johnson & Johnson Impact Ventures (JJIV), an impact investment fund within the Johnson & Johnson Foundation, is to target this goal through a lens of health equity. We invest in companies and entrepreneurs innovating new market-based solutions that provide access to quality and affordable healthcare for underserved communities around the world.

Companies in our portfolio are addressing this based on different regional needs and opportunities. For example, some are focused on bridging the socioeconomic gap in healthcare accessibility in low- and middle-income countries, while others are working to reduce racial inequities within healthcare delivery in the U.S. But, the consistent theme is our mission to help support and scale sustainable business models that are improving the health of communities that would not otherwise have access. In that spirit, JJIV is excited to welcome three new companies to our portfolio:

  • Certintell: A telehealth company working to increase access to virtual care solutions and remote patient monitoring for communities of color in the U.S.
  • Clinify Health: A healthtech company utilizing data solutions to make personalized, culturally competent care more accessible to under-resourced communities.
  • Penda Health: A network of primary care clinics with integrated telehealth in Kenya providing lower-     cost but high-quality health services.

It’s been an exciting start to the year at JJIV. Learn more about what our portfolio and program partners have been up to these past few months by visiting our news page.


Dana Deardorff, Global Director
Johnson & Johnson Impact Ventures

Subscribe to read the full newsletter and receive updates from JJIV in the future.